279 related articles for article (PubMed ID: 26990863)
1. A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies.
Marciani DJ
J Neurochem; 2016 Jun; 137(5):687-700. PubMed ID: 26990863
[TBL] [Abstract][Full Text] [Related]
2. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
3. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
4. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
5. Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine.
Kabir MT; Uddin MS; Mathew B; Das PK; Perveen A; Ashraf GM
Curr Top Med Chem; 2020; 20(13):1214-1234. PubMed ID: 32321405
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
7. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
[TBL] [Abstract][Full Text] [Related]
8. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
Marciani DJ
Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
[TBL] [Abstract][Full Text] [Related]
9. 'Clinical trials in Alzheimer's disease': immunotherapy approaches.
Delrieu J; Ousset PJ; Caillaud C; Vellas B
J Neurochem; 2012 Jan; 120 Suppl 1():186-193. PubMed ID: 21883222
[TBL] [Abstract][Full Text] [Related]
10. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease vaccine development: A new strategy focusing on immune modulation.
Marciani DJ
J Neuroimmunol; 2015 Oct; 287():54-63. PubMed ID: 26439962
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine.
Yu YZ; Xu Q
Hum Vaccin Immunother; 2016 Nov; 12(11):2801-2804. PubMed ID: 27379885
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
[TBL] [Abstract][Full Text] [Related]
14. Rejecting the Alzheimer's disease vaccine development for the wrong reasons.
Marciani DJ
Drug Discov Today; 2017 Apr; 22(4):609-614. PubMed ID: 27989721
[TBL] [Abstract][Full Text] [Related]
15. Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.
Vasilevko V; Pop V; Kim HJ; Saing T; Glabe CC; Milton S; Barrett EG; Cotman CW; Cribbs DH; Head E
Neurobiol Dis; 2010 Sep; 39(3):301-10. PubMed ID: 20451612
[TBL] [Abstract][Full Text] [Related]
16. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
17. Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine.
Carrera I; Fernandez-Novoa L; Aliev G; Vigo C; Cacabelos R
Curr Pharm Des; 2016; 22(7):849-58. PubMed ID: 26648469
[TBL] [Abstract][Full Text] [Related]
18. Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.
Movsesyan N; Davtyan H; Mkrtichyan M; Petrushina I; Tiraturyan T; Ross T; Agadjanyan MG; Ghochikyan A; Cribbs DH
Hum Gene Ther; 2010 Nov; 21(11):1569-76. PubMed ID: 20528468
[TBL] [Abstract][Full Text] [Related]
19. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules.
Davtyan H; Zagorski K; Rajapaksha H; Hovakimyan A; Davtyan A; Petrushina I; Kazarian K; Cribbs DH; Petrovsky N; Agadjanyan MG; Ghochikyan A
Sci Rep; 2016 Jul; 6():28912. PubMed ID: 27363809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
